Where can I get Napavir sodium/Salanka long-acting injection?
Lenapavir sodium/Sunlenca (Sunlenca) is a long-acting HIV (AIDS) treatment drug, and its injection form has attracted much attention in clinical application. Since the drug is administered by subcutaneous injection, its efficacy can last for half a year, greatly reducing the patient's medication frequency and helping to improve compliance. The emergence of long-acting injectable drugs is seen as an important advance in improving patients' quality of life compared with daily oral antiretroviral drugs.
In terms of injection route, long-acting injections of lenapavir sodium are usually operated by medical institutions with qualifications in infectious diseases or immunology. Currently in overseas markets, patients need to go to designated hospitals or specialized HIV clinics, where doctors will administer injections under strict supervision. Due to the long half-life of the drug, which can last for approximately 26 weeks after one injection, the standardization requirements for medical operations are very high to ensure that the drug can be slowly released under the skin to achieve sustained antiviral effects.
In China, since lenapavir sodium injection has just been launched, it has not yet been widely used. If necessary, most patients need to go to the infectious diseases department of a large hospital or the HIV-specific outpatient clinic for consultation. At present, key infectious disease prevention and treatment centers and designated hospitals for AIDS diagnosis and treatment in some provinces and cities may gradually introduce the drug, but the coverage is still relatively limited. Patients need to be evaluated by a doctor before use, including past drug resistance history, medication history, and current virological status, to ensure that they are suitable for receiving a long-acting injection regimen.
It is worth noting that lenapavir sodium injection is not used alone, but as part of a combination regimen, usually in combination with other antiretroviral drugs to achieve the best virological suppression effect. Therefore, patients cannot rely solely on injections, but also need to be combined with a doctor's treatment plan.
Reference materials:https://www.drugs.com/sunlenca.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)